List of Samsca drug patents

Samsca is owned by Otsuka.

Samsca contains Tolvaptan.

Samsca has a total of 2 drug patents out of which 0 drug patents have expired.

Samsca was authorised for market use on 19 May, 2009.

Samsca is available in tablet;oral dosage forms.

The generics of Samsca are possible to be released after 07 April, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8501730 OTSUKA Process for preparing benzazepine compounds or salts thereof
Sep, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10905694 OTSUKA Pharmaceutical solid preparation comprising benzazepines and production method thereof
Apr, 2030

(7 years from now)

Drugs and Companies using TOLVAPTAN ingredient

Market Authorisation Date: 19 May, 2009

Treatment: NA


How can I launch a generic of SAMSCA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic